Krempa David bought ETON
May 26, 2026 · Form 4 insider transaction
Krempa David bought 12,524 shares of Eton Pharmaceuticals, Inc. at $1.37 per share, a transaction worth $17.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
12,524
Price
$1.37
Total value
$17.2K
InsiderKrempa David
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 26, 2026
Filing dateMay 27, 2026
Shares owned after62,773
OwnershipDirect
10b5-1 planNo
AmendedNo